Applications of Genetic Polymorphism in Anthropology and Medicine

A blood sample from a crime scene, a DNA test in a paternity dispute, a matched kidney donor, a pill that works for one patient but triggers a dangerous reaction in another – all of these rely on the same biological fact: no two people (except identical twins) carry exactly the same genetic code. This variation, called genetic polymorphism, is far more than a textbook term. It is the raw material that lets researchers trace where a population came from, doctors predict who is at risk of disease, and courts settle questions of identity. Here is how one concept from population genetics ends up shaping anthropology, medicine, and law.

What makes a polymorphism useful 🔗

A genetic polymorphism is simply a DNA sequence that varies between individuals in a population, with each variant (or allele) common enough that it isn’t just a rare mutation. Blood groups, short tandem repeats (STRs), and single nucleotide polymorphisms (SNPs) are the most widely used markers. Because these variants are inherited in predictable patterns and differ in frequency across populations, they become a kind of biological fingerprint – one that can answer questions ranging from “where did my ancestors migrate from” to “will this drug work for me.”

Tracing population history and affinities 🔗

When researchers want to understand how populations are related, they compare DNA sequences from individuals across different groups. Shared alleles and similar frequency patterns point to common ancestry or historical contact, while sharp differences suggest long periods of isolation. This approach has been central to anthropological genetics since the discovery of DNA-based markers, and it has been used to reconstruct human origins, migration routes, and the effects of admixture between groups. In the Indian context, this kind of analysis has helped explain the genetic layering seen across linguistic and geographic groups, reflecting waves of migration and mixing over thousands of years.

Reconstructing demographic history 🔗

Polymorphic markers don’t just show who is related to whom – they also carry information about population size over time. A population that went through a bottleneck (a sharp drop in numbers due to famine, disease, or displacement) tends to show reduced genetic diversity, because many alleles present before the bottleneck simply didn’t survive by chance. A population that expanded rapidly, on the other hand, tends to show excess rare variants. By modelling these patterns statistically, geneticists can infer whether a population grew, shrank, split, or merged with another group long before any written records existed.

Reading mutation patterns to date the past 🔗

Mutations accumulate in DNA at roughly predictable rates, and this fact turns polymorphisms into a kind of molecular clock. Fast-mutating markers like STRs are useful for dating relatively recent events – a few hundred to a few thousand years – while slower-mutating SNPs are better suited to tracing divergence over tens of thousands of years. By comparing how much two populations’ DNA sequences have diverged, and applying an estimated mutation rate, researchers can put approximate dates on events such as when two groups separated or when a particular gene variant first arose. This is the same logic used to estimate when anatomically modern humans dispersed out of Africa and when various sub-populations branched off from one another.

Mapping disease genes and predicting risk 🔗

Polymorphisms are also central to modern medical genetics. In a genome-wide association study (GWAS), researchers scan the genomes of thousands of people with and without a particular disease, looking for SNPs that occur more often in the affected group. Variants that show a strong statistical association are flagged as potential contributors to that disease. Because most common conditions – diabetes, heart disease, several cancers – are influenced by many genes acting together rather than a single mutation, scientists now combine information from dozens or hundreds of SNPs into a single number called a polygenic risk score, which estimates an individual’s inherited likelihood of developing a condition. This score has already shown promise in identifying high-risk subgroups for diseases such as coronary artery disease, obesity, and diabetes, moving medicine a step closer to genuinely personalised prevention and treatment plans rather than one-size-fits-all guidelines.

Forensic identification and paternity testing 🔗

Perhaps the most publicly visible application of genetic polymorphism is forensic DNA profiling. Because STR markers vary so much between unrelated individuals, a person’s profile across a standard panel of these markers is, for all practical purposes, unique. This is why DNA evidence is now treated as close to conclusive in court, provided samples are collected and analysed correctly. In India, the technique was pioneered indigenously at the Centre for Cellular and Molecular Biology in the late 1980s, and it has since been used in hundreds of paternity disputes, cases of mutilated or unidentified bodies, baby-swap incidents in hospitals, and criminal investigations involving rape and murder. The specialised institution set up to carry this work forward, the Centre for DNA Fingerprinting and Diagnostics in Hyderabad, continues to support police, courts, and lawyers with DNA-based evidence today.

Beyond crime: identity and inheritance 🔗

The same technology settles questions well outside the criminal justice system – confirming biological parentage in inheritance disputes, reuniting missing children with their families, and verifying relationships for immigration purposes. In each case, the underlying principle is identical: compare the pattern of inherited polymorphic markers between two people and calculate the statistical likelihood that they are related.

Matching donors for organ and marrow transplants 🔗

Successful organ and bone marrow transplantation depends heavily on matching a set of highly polymorphic genes known as the human leukocyte antigen (HLA) system. HLA genes code for proteins that help the immune system distinguish the body’s own cells from foreign ones, and because these genes have an unusually large number of possible variants, finding a well-matched donor can be genuinely difficult. Transplant outcomes tend to be considerably better when donor and recipient HLA types are closely matched, in addition to compatible blood groups, which is why organ registries and bone marrow donor databases rely so heavily on HLA typing before a match is confirmed.

Understanding drug response and unexpected side effects 🔗

The same HLA variation that governs transplant compatibility also helps explain why a drug that is perfectly safe for most people can cause a severe reaction in others. Certain HLA alleles are strongly associated with serious drug hypersensitivity reactions, including life-threatening skin conditions triggered by specific anticonvulsant and anti-gout medications. Because the frequency of these risk alleles varies significantly across populations and ethnic groups, pharmacogenomic screening before prescribing certain drugs is increasingly recommended, particularly in regions where a specific high-risk allele is common. This is the essence of personalised medicine: using an individual’s own polymorphic profile, rather than population averages, to guide treatment decisions.

Why this matters beyond the classroom 🔗

Genetic polymorphism sits at the intersection of evolutionary biology, forensic science, and clinical medicine, which is exactly what makes it such a rich topic in human population genetics. The same handful of variable DNA markers that anthropologists use to trace ancient migrations are, with a different analytical lens, used by a hospital to find a matching kidney donor or by a court to settle a paternity case. Understanding polymorphism, in other words, is understanding one of the few genuinely interdisciplinary threads running through the study of human variation.

What do you think? If a single set of genetic markers can reveal ancient migration routes and also predict how someone might react to a common medicine, where else do you think this dual identity – history on one side, medicine on the other – could open up new research questions? And as genetic testing becomes cheaper and more widespread in India, what safeguards do you think are needed to make sure this data is used responsibly?

References

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831593/
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212479/
3. https://www.csir.res.in/en/csir-success-stories/dna-fingerprinting-technology-its-success-and-future
4. https://www.ebsco.com/research-starters/health-and-medicine/organ-transplants-and-hla-genes
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622011/